Eric Olson, PhD
Vice President and Program Leader
Vertex Pharmaceuticals Incorporated

Eric Olson, PhD, is a Vice President and Program Leader at Vertex Pharmaceuticals Incorporated in Cambridge, MA, where he works on cystic fibrosis and antibiotic drug discovery and development programs. He co-leads the Vertex and the CF Foundation Therapeutics Joint Development Committee that provides oversight and strategy for development of two CF compounds: VX-770, a CFTR potentiator currently in Phase 2, and VX-809, a CFTR corrector currently in Phase 1.

Prior to joining Vertex, he was at Warner-Lambert (now Pfizer) for 11 years and Upjohn Pharmaceuticals (now Pfizer) for six years, focusing on bacterial gene expression and new antibiotic discovery. His formal training is in Microbiology with a BS from the University of Minnesota, a PhD from the University of Michigan, and post-doctoral studies at McGill University.